Pharma Giants Collaboration Accelerates Access to Rare Disease Treatment – Hear more at Orphan Drugs & Rare Diseases 2018 Read more
Dr. Reddy’s Laboratories Announces the Sale of Its Antibiotic Manufacturing Site and Its Related Assets in Bristol, Tennessee Read more
Vertex Announces Access Contract in Denmark for Current and Future Cystic Fibrosis Medicines Read more
Innovent Receives an Approval from FDA to Initiate Clinical Trials for its Anti-CD47 Monoclonal Antibody IBI-188 Read more